The goal of this program is to improve management of immune thrombocytopenia, management of myeloma, and management of solid tumors with adoptive T cell therapy. After hearing and assimilating this program, the clinician will be better able to: 1. Select drugs for treatment of immune thrombocytopenia. 2. Identify patients who are candidates for splenectomy. 3. Advise patients with myeloma to undergo autologous stem cell transplantation (ASCT). 4. Choose a regimen of maintenance therapy to follow induction therapy and ASCT in patients with myeloma. 5. Match patients with solid tumors with the appropriate adoptive cell therapy.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https://www.audio-digest.org/Specialties/Oncology
- Start Date: 2023-02-15 06:00:00
- End Date: 2023-02-15 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 2.0 hours
- MOC Credit Details: ABIM - 2.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology
Subscribe
Login
0 Comments
Oldest